Executive interview – ASIT Biotech

Published on 23 July 2019
 

In this interview Michel Baijot, CEO of Asit Biotech, discusses what is unique about the company and what newsflow investors can expect from ASIT in the second half of 2019.

Share this with friends and colleagues